home.aspx
 
EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...

Cell & Gene Therapy Manufacturing

The race towards commercialisation of cell and gene products has already begun. Where technology innovations are pathing the way towards the development of these products, challenges surrounding scale up and closed system processing highlight areas that need our focus so that cell and gene therapy products can be produced on an industrial scale The Cell and Gene Therapy Manufacturing Forum is the only conference that is 100% dedicated to focusing on development of manufacturing processes for these products. With presentations on improving cost efficiency, innovative strategies for commercialisation as well as closed system processing, optimised manufacturing scheduling and maintaining GMP compliance, this forum is one that is not to be missed!

RELATED NEWS


A new treatment hailed as ‘groundbreaking’ has been rolled out across the country as part of the NHS' Long Term Plan, and could see as many as 2,000 patients benefit as a result. 5-ALA (5-AminoLevulinic Acid), dubbed ‘the pink drink’, uses fluorescent dye and ultraviolet light to make cancerous cells glow under UV light, enabling surgeons to more accurately identify the affected areas of the brain. This method will help to tackle some of the hardest to treat cases and...

READ MORE

HiberCell, based in New York City, launched with a $60.75 million Series A funding. The funding was led by ARCH Venture Partners. Additional investors included Hillhouse Capital, 6 Dimensions Capital, Celgene Corporation, the NYC Life Sciences Fund, and other undisclosed investors. HiberCell focuses on tumor dormancy detection and treatments. Recurrence of cancer, which is the cause of many cancer deaths, is driven by dormant disseminated tumor cells (DTCs) that remain undetected in the body for...

READ MORE

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use. The National Institute for Health and Care Excellence said it is not recommending NHS funding for Kisplyx (lenvatinib) in combination with everolimus for previously treated patients because of uncertainties in the clinical evidence. While trial data suggest...

READ MORE

The study, funded by Cancer Research UK and published in Nature Immunotherapy, showed that lung cancer patients with a high level of tissue-resident memory T-cells in their tumour were 34 percent less likely to die....

READ MORE

EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...